Singapore Markets open in 1 hr 3 mins

AnPac Bio-Medical Science Co., Ltd. (ANPC)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
6.53-0.07 (-1.06%)
At close: 03:55PM EDT

AnPac Bio-Medical Science Co., Ltd.

801 Bixing Street
Bihu County
Lishui 323006
China
86 57 8205 1666
https://www.anpacbio.com

Sector(s)Healthcare
IndustryBiotechnology
Full-time employees89

Key executives

NameTitlePayExercisedYear born
Dr. Chris Chang YuCo-Founder, Co-CEO & Co-ChairmanN/AN/A1958
Mr. Haohan XuCo-CEO & Co-ChairpersonN/AN/A1995
Dr. He YuCo-Founder & Chief Medical OfficerN/AN/A1958
Ms. Xiaoyu LiCFO & DirectorN/AN/A1989
Mr. Weidong DaiChina PresN/AN/A1961
Dr. Sunil PanditU.S. Chief Exec. OfficerN/AN/AN/A
Amounts are as of , and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

AnPac Bio-Medical Science Co., Ltd., a biotechnology company, researches, develops, markets, and sells multi-cancer screening and detection tests using cancer differentiation analysis technology and device to corporations and life insurance companies in the People's Republic of China. It also offers physical checkup package services. The company was incorporated in 2010 and is headquartered in Lishui, the People's Republic of China.

Corporate governance

AnPac Bio-Medical Science Co., Ltd.’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.